Showing results (411-420 of 682) with videos related to
Sort By:
Pageof 69
Blood|March 1, 1985
Hairy cell leukemia: a tumor of pre-plasma cellsK C Anderson, A W Boyd, D C Fisher, et al.The New England Journal of Medicine|January 8, 1987
Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibodyC Morimoto, D A Hafler, H L Weiner, et al.The Journal of Experimental Medicine|November 1, 1978
Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigensR L Evans, T J Faldetta, R E Humphreys, et al.The Journal of Clinical Investigation|August 1, 1994
Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantationK Sugita, Y Nojima, K Tachibana, et al.The Journal of Experimental Medicine|October 1, 1990
VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectinY Nojima, M J Humphries, A P Mould, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
B5, a new B cell-restricted activation antigenA S Freedman, A W Boyd, K C Anderson, et al.Proceedings of the National Academy of Sciences of the United States of America|May 17, 2000
Secreted and membrane attractin result from alternative splicing of the human ATRN geneW Tang, T M Gunn, D F McLaughlin, et al.Journal of Immunological Methods|July 29, 1983
Isolation and characterization of human B lymphocyte enriched populations. I. Purification of B cells by immune rosette depletionK C Anderson, J D Griffin, M P Bates, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytesL M Nadler, K C Anderson, G Marti, et al.International Immunology|June 30, 2001
B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patientsS Jacquot, L Maçon-Lemaître, E Paris, et al.Pageof 69